search twitter-square facebook-square linkedin-square google-plus-square bars navigate_next
  • Creso secures binding loi for animal health products
  • quarterly activities report & appendix 4c
  • commercial distribution agreement to bring first revenues

Bringing pharmaceutical industry expertise to the world of medicinal cannabis.

A nutraceutical approach for both human and animal health markets.

Creso Pharma is working to develop and produce safe, cannabis- and hemp- derived therapeutic products and treatments for humans and pets.

Creso Pharma is a uniquely positioned nutraceutical and medical cannabis company, emerging in what is predicted to be a US$ 385 billion industry.

Working according to Good Manufacturing Practices (GMP) standards, Creso Pharma’s pharmaceutical-grade Nutraceuticals and Medical Cannabis products are delivered with standardised dosing and formulations, and use proprietary innovative delivery technologies to enhance the bioavailability and absorption of the cannabinoid molecules.

These products are designed to create better overall health in humans and pets.

Creso Pharma’s unique cannabinoid products aim to re-establish and bolster the balance of the body’s internal endocannabinoid system, maintain homeostasis, and alleviate a wide range of symptoms for the following medical conditions: pain and anxiety disorders, metabolic disorders and inflammatory disorders.

Creso Pharma’s products will supplement unbalanced, naturally occurring endocannabinoids with cannabinoids from the cannabis plant, naturally synergising with the body’s own endocannabinoid system.

Creso Pharma’s innovative CBD fully plant-based nutraceutical products are non-psychoactive, as they contain only trace amounts of THC.

Creso Pharma’s highly experienced pharmaceutical management team and board have a strong track record of success and many years of experience in developing and commercialising a wide range of medical and therapeutic solutions, and will be instrumental in Creso Pharma achieving its ‘go to market’ strategies.

Through worldwide distribution rights and commercialisation partners, Creso Pharma is able to develop the most competitive pharmaceutical-grade Nutraceuticals and Medical Cannabis products on the market today.

CRESO PHARMA AQUIRES CANADIAN BASED MERNOVA MEDICINA
Stay Informed with latest news and product developments

To receive our alerts fill in your details below.

Keep me informed